Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Galapagos presents new sphingosine 1-phosphate receptor antagonists

Sep. 19, 2017

Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation

Sep. 19, 2017

FDA issues complete response letter for Ryanodex

July 27, 2017

Unity Biotechnology patents Bcl-W, Bcl-XL and Bcl-2 inhibitors

July 12, 2017

GlaxoSmithKline describes novel CPHPC prodrugs

May 24, 2017

FDA grants priority review to Ryanodex NDA to treat exertional heat stroke

March 28, 2017

Santen Pharmaceutical patents glucocorticoid receptor agonists

March 24, 2017

Mouse model developed for the study of alpha-gal meat allergy

March 14, 2017

TiGenix initiates phase Ib/IIa trial of Cx-611 to treat sepsis in community-acquired pneumonia

Jan. 31, 2017

Eagle Pharmaceuticals completes NDA submission for Ryanodex

Jan. 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...